Clinical Trial With Vinflunine as Maintenance Therapy in Metastatic Urothelial Cancer
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This is a clinical trial to evaluate the efficacy and safety of the drug vinflunine
administered after the standard treatment of the combination gemcitabine+cisplatin, when it
has reached stabilization or response of the disease, as the first treatment inmeditely after
the diagnosis of advanced or metastatic urothelial cancer.